| BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells D Sarkar, B Shields, ML Davies, J Müller, JA Wakeman International journal of cancer 130 (2), 328-337, 2012 | 79 | 2012 |
| Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell–dependent induction of CD4+CD25+FoxP3+ Treg M Biswas, D Sarkar, SRP Kumar, S Nayak, GL Rogers, DM Markusic, ... Blood, The Journal of the American Society of Hematology 125 (19), 2937-2947, 2015 | 73 | 2015 |
| Ex vivo expanded autologous polyclonal regulatory T cells suppress inhibitor formation in hemophilia D Sarkar, M Biswas, G Liao, HR Seay, GQ Perrin, DM Markusic, ... Molecular therapy Methods & clinical development 1, 2014 | 69 | 2014 |
| Prevention and reversal of antibody responses against factor IX in gene therapy for hemophilia B S Nayak, D Sarkar, GQ Perrin, B Moghimi, BE Hoffman, S Zhou, BJ Byrne, ... Frontiers in microbiology 2, 244, 2011 | 51 | 2011 |
| Comparison of growth and yield characteristics of BARI tomato varieties M Biswas, DR Sarkar, MI Asif, RK Sikder, H Mehraj, AFM Jamal Uddin Journal of Bioscience and Agriculture Research 3 (1), 1-7, 2014 | 27 | 2014 |
| Effect of nitrogen levels on morphological and yield response of BARI tomato-9 M Biswas, DR Sarkar, MI Asif, RK Sikder, H Mehraj, AFM Jamal Uddin Journal of Science, Technology and Environment Informatics 1 (2), 68-74, 2015 | 18 | 2015 |
| Retinal Tropism of In Silico Reconstructed Ancestral Adeno-Associated Viruses LS Carvalho, E Zinn, S Shah, R Xiao, D Sarkar, V Khaychuk, ... MOLECULAR THERAPY 22, S45-S45, 2014 | 1 | 2014 |
| 293. Optimal In Vivo Treg Induction and Suppression of Immune Responses By Synergistic Use of Rapamycin and FLT3 Ligand M Biswas, D Sarkar, S Nayak, SRP Kumar, GL Rogers, DM Markusic, ... Molecular Therapy 23, S118, 2015 | | 2015 |
| Pre-existing immunity to AAV overcome by in silico ancestral capsid design E Zinn, V Khaychuk, D Sarkar, L Carvalho, S Pacouret, H Morris, E Plovie, ... HUMAN GENE THERAPY 25 (11), A8-A8, 2014 | | 2014 |
| Seroprevalence Assessment of Novel, Ancestrally Derived AAV Vectors D Sarkar, E Plovie, E Zinn, V Khaychuk, L Carvalho, LH Vandenberghe MOLECULAR THERAPY 22, S74-S74, 2014 | | 2014 |
| Characterization of Ex Vivo Expanded Tregs for Suppression of Immune Responses in Hemophilia Treatment M Biswas, D Sarkar, D Markusic, G Perrin, C Terhorst, TM Brusko, ... MOLECULAR THERAPY 22, S304-S305, 2014 | | 2014 |
| 237. In Silico, Ancestral Reconstruction of AAV Particles Circumvents Pre-Existing Immunity in Humans E Zinn, E Plovie, D Sarkar, V Khaychuk, L Carvalho, S Shah, ... Molecular Therapy 22, 1, 2014 | | 2014 |
| Enhanced Liver Transduction With Novel AAV Resistant To Pre-Existing Immunity in Humans V Khaychuk, E Zinn, E Plovie, D Sarkar, L Carvalho, S Shah, ... MOLECULAR THERAPY 22, S225-S225, 2014 | | 2014 |
| 109. Ex Vivo Expanded Treg Suppress Inhibitor Formation in Protein and Gene Therapies for Hemophilia D Sarkar, DM Markusic, TM Brusko, RW Herzog Molecular Therapy 21, 1, 2013 | | 2013 |
| Suppression of Inhibitor Formation in Protein and Gene Therapy for Hemophilia Using Ex Vivo Expanded Treg D Sarkar, DM Markusic, C Terhorst, T Brusko, RW Herzog Blood 120 (21), 13, 2012 | | 2012 |
| Synergistic Effect of Flt3L and Rapamycin On Immune Tolerance Induction Via Plasmacytoid Dendritic Cells and Treg. D Sarkar, G Liao, C Terhorst, RW Herzog Blood 120 (21), 2209, 2012 | | 2012 |
| Gene Therapists Determined to Stop the Bleeding D Sarkar, GQ Perrin, S Zolotukhin, A Srivastava, RW Herzog J Genet Syndr Gene Ther S 1, 2, 2012 | | 2012 |
| Brachyury goes Clinical D Sarkar JOURNAL OF PROTEOMICS AND BIOINFORMATICS 5 (12), 25, 2012 | | 2012 |
